{"id":2145,"date":"2017-06-23T13:45:56","date_gmt":"2017-06-23T13:45:56","guid":{"rendered":"http:\/\/blogs.cardiff.ac.uk\/alumni\/?p=2145"},"modified":"2022-04-13T16:14:24","modified_gmt":"2022-04-13T16:14:24","slug":"chinese-investment-in-cardiff-universitys-biomedical-research","status":"publish","type":"post","link":"https:\/\/blogs.cardiff.ac.uk\/alumni\/2017\/06\/23\/chinese-investment-in-cardiff-universitys-biomedical-research\/","title":{"rendered":"Chinese investment in Cardiff University\u2019s biomedical research"},"content":{"rendered":"

\"\"<\/a><\/p>\n

Cardiff University is joining forces with a major Chinese biomedical service provider to explore key biomedical and clinical research opportunities.<\/p>\n

Realcan, which operates primarily in China, will provide funding of \u00a31m to Cardiff University over a three-year period. The collaboration will focus on Cardiff University College of Biomedical & Life Sciences key research themes: cancer; integrative biosystems; mind, brain and neuroscience; immunology, infection and inflammation; and population health. The \u00a31m investment will provide funding for Realcan PhD students to partner with the University\u2019s leading clinicians and biomedical scientists, and Realcan research fellows.<\/p>\n

The University has around 40 partnerships across China including major collaborations with Peking University and Beijing Friendship Hospital (Capital Medical University) as part of the Cardiff China Medical Research Collaborative (CCMRC), which focuses on oncology research. The backbone of CCMRC is the University Joint Cancer Institute where Cardiff University and Peking University have worked together since 1999 researching the cause, diagnosis and treatment of cancer.<\/p>\n

Speaking about the agreement, Cardiff University Vice-Chancellor and President, Professor Colin Riordan, said: \u201cOur links with China are strong and I am delighted that we have the opportunity to further develop our already successful research partnerships in the country. Realcan shares our vision for world leading research to tackle pressing global health challenges. The investment will also enable us to invest in the brightest and best postgraduate researchers.\u201d<\/p>\n

Professor Wen G Jiang MBE, a leading researcher from Cardiff University\u2019s School of Medicine, said: \u201cCardiff University\u2019s Medical School, part of our College of Biomedical & Life Sciences, is involved in cutting edge science and world class research in the field of medicine that has a real impact<\/a> on people’s lives. We have established many successful collaborations with China and our latest partnership offers further exciting opportunities for biomedical and clinical research with experts in Chinese universities. We are very grateful to Realcan for this significant investment.\u201d<\/p>\n

Mr Xu Han, Chairman of RealCan, said: \u201cWe are highly impressed with the biomedical and clinical work that is carried out at Cardiff University, one of the world leaders in this type of research. The world faces many health challenges and it is only through working closely together across countries and continents that we can make a real difference to people\u2019s lives.\u201d<\/p>\n

The agreement has received wide praise\u00a0both in China and the UK with \u00a0Mr Yongli Wang, Minister Counsellor for Education at the Chinese Embassy in London, saying: \u201c<\/em>China has a long record of working with institutions in Wales, and indeed the whole of the United Kingdom, and we warmly welcome this agreement between Cardiff University and one of our most successful companies.\u201d Mr Kevin Holland, the Minister-Counsellor and Director for Life Sciences, Health and Social Care, at the British Embassy in Beijing, said: \u201cI am very pleased to see the developing relationship between Realcan and Cardiff University and their research partnership programme. We fully support their goals to discover new medicines and therapies which access the best of British science to improve the lives of patients in both UK and China.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Cardiff University is joining forces with a major Chinese biomedical service provider to explore key biomedical and clinical research opportunities.","protected":false},"author":1080,"featured_media":2148,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[142,4],"tags":[121],"class_list":["post-2145","post","type-post","status-publish","format-quote","has-post-thumbnail","hentry","category-donate","category-news","tag-news","post_format-post-format-quote"],"meta_box":[],"_links":{"self":[{"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/posts\/2145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/users\/1080"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/comments?post=2145"}],"version-history":[{"count":10,"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/posts\/2145\/revisions"}],"predecessor-version":[{"id":2156,"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/posts\/2145\/revisions\/2156"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/media\/2148"}],"wp:attachment":[{"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/media?parent=2145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/categories?post=2145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/alumni\/wp-json\/wp\/v2\/tags?post=2145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}